Two Year Outcome After Chronic Iliac Vein Occlusion Recanalisation Using the Vici Venous Stent®

Stephen Black, Prakash Saha(King's College London), Beverley J. Hunt, Justinas Silickas(King's College London), Karen Breen(University College London Hospitals NHS Foundation Trust), Ander Cohen(Guy's and St Thomas' NHS Foundation Trust), Adam Gwozdz(King's College London), Alberto Smith(St Thomas' Hospital), Narayan Karunanithy(Guy's and St Thomas' NHS Foundation Trust)
European Journal of Vascular and Endovascular Surgery
August 20, 2018
10.1016/j.ejvs.2018.07.014
Cited by 84

Related Papers

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies
|British Journal of Haematology|2012|861
Editor's Choice – European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis
|European Journal of Vascular and Endovascular Surgery|2020|709
A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura
|Blood|2011|420
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial
|The Lancet Haematology|2016|404